(VIANEWS) – Crescent Capital BDC (CCAP), Kiniksa Pharmaceuticals, Ltd. (KNSA), Entergy Louisiana, LLC First Mortgage Bonds, 5.875% (ELA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. Crescent Capital BDC (CCAP)
36.8% sales growth and 4.48% return on equity
Crescent Capital BDC, Inc. is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.
Earnings Per Share
As for profitability, Crescent Capital BDC has a trailing twelve months EPS of $0.87.
PE Ratio
Crescent Capital BDC has a trailing twelve months price to earnings ratio of 19.1. Meaning, the purchaser of the share is investing $19.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.48%.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Sep 27, 2023, the estimated forward annual dividend rate is 1.64 and the estimated forward annual dividend yield is 9.59%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 74.6%, now sitting on 149.1M for the twelve trailing months.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 33.3% and 12.2%, respectively.
2. Kiniksa Pharmaceuticals, Ltd. (KNSA)
15.5% sales growth and 81.84% return on equity
Kiniksa Pharmaceuticals, Ltd., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases with significant unmet medical need worldwide. Its product candidates include Rilonacept, which is in Phase III clinical trials for the treatment of recurrent pericarditis, an inflammatory cardiovascular disease; Mavrilimumab, a monoclonal antibody that is in Phase II clinical trials for the treatment of giant cell arteritis; and Vixarelimab, a monoclonal antibody, which is in Phase 2a clinical trial for the treatment of prurigo nodularis, a chronic inflammatory skin condition. The company's preclinical product candidates comprise KPL-404, a monoclonal antibody inhibitor of the CD40/CD40L interaction, a central control node of T-cell-dependent, and B-cell-mediated humoral adaptive immunity. The company has a clinical collaboration with Kite Pharma, Inc. to evaluate the combination of Yescarta and Mavrilimumab in patients with relapsed or refractory Large B-Cell lymphoma. Kiniksa Pharmaceuticals, Ltd. was founded in 2015 and is based in Hamilton, Bermuda.
Earnings Per Share
As for profitability, Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months EPS of $3.12.
PE Ratio
Kiniksa Pharmaceuticals, Ltd. has a trailing twelve months price to earnings ratio of 5.1. Meaning, the purchaser of the share is investing $5.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 81.84%.
Volume
Today’s last reported volume for Kiniksa Pharmaceuticals, Ltd. is 13984 which is 97.08% below its average volume of 480228.
Moving Average
Kiniksa Pharmaceuticals, Ltd.’s worth is below its 50-day moving average of $17.44 and above its 200-day moving average of $14.55.
Revenue Growth
Year-on-year quarterly revenue growth grew by 165%, now sitting on 280.84M for the twelve trailing months.
3. Entergy Louisiana, LLC First Mortgage Bonds, 5.875% (ELA)
13.2% sales growth and 32.75% return on equity
Envela Corporation, together with its subsidiaries, primarily buys and sells jewelry and bullion products to individual consumers, dealers, Fortune 500 companies, municipalities, school districts, and other organizations in the United States. It offers jewelry and fine-watch products, including bridal jewelry, fashion jewelry, custom-made jewelry, diamonds, and other gemstones, as well as watches and jewelry components. The company also buys and sells various forms of gold, silver, platinum, and palladium products, including United States and other government coins, private mint medallions, art bars, and trade unit bars; and numismatic items, such as rare coins, currency, medals, tokens, and other collectibles, as well as provides jewelry and watches repair services. In addition, it offers end-of-life electronics recycling services; disposal transportation and product tracking services; IT-asset disposition services, including compliance and data sanitization services; and services to companies in the areas of software upgrades, and hardware or networking capabilities, as well as moving to cloud services. As of December 31, 2021, Envela Corporation marketed its products and services through six retail locations under the Dallas Gold & Silver Exchange name; and one retail location under the Charleston Gold & Diamond Exchange name, as well as through cgdeinc.com, dgse.com, echoenvironmental.com, ITADUSA.com, availrecovery.com, and teladvance.com e-commerce sites. The company was formerly known as DGSE Companies, Inc. and changed its name to Envela Corporation in December 2019. Envela Corporation was incorporated in 1965 and is headquartered in Irving, Texas.
Earnings Per Share
As for profitability, Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months EPS of $0.49.
PE Ratio
Entergy Louisiana, LLC First Mortgage Bonds, 5.875% has a trailing twelve months price to earnings ratio of 9.02. Meaning, the purchaser of the share is investing $9.02 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.75%.
Moving Average
Entergy Louisiana, LLC First Mortgage Bonds, 5.875%’s worth is way under its 50-day moving average of $5.37 and way under its 200-day moving average of $6.45.
Earnings Before Interest, Taxes, Depreciation, and Amortization
Entergy Louisiana, LLC First Mortgage Bonds, 5.875%’s EBITDA is 77.91.
Yearly Top and Bottom Value
Entergy Louisiana, LLC First Mortgage Bonds, 5.875%’s stock is valued at $4.42 at 20:22 EST, way under its 52-week high of $8.05 and above its 52-week low of $4.30.
4. JP Morgan Chase (JPM)
8.7% sales growth and 16.93% return on equity
JPMorgan Chase & Co. operates as a financial services company worldwide. It operates through four segments: Consumer & Community Banking (CCB), Corporate & Investment Bank (CIB), Commercial Banking (CB), and Asset & Wealth Management (AWM). The CCB segment offers deposit, investment and lending products, cash management, and payments and services to consumers and small businesses; mortgage origination and servicing activities; residential mortgages and home equity loans; and credit cards, auto loans, leases, and travel services. The CIB segment provides investment banking products and services, including corporate strategy and structure advisory, and equity and debt markets capital-raising services, as well as loan origination and syndication; payments and cross-border financing; and cash and derivative instruments, risk management solutions, prime brokerage, and research. This segment also offers securities services, including custody, fund accounting and administration, and securities lending products for asset managers, insurance companies, and public and private investment funds. The CB segment provides financial solutions, including lending, payments, investment banking, and asset management to small and midsized companies, local governments, nonprofit clients, and large corporations; and commercial real estate banking services to investors, developers, and owners of multifamily, office, retail, industrial, and affordable housing properties. The AWM segment offers multi-asset investment management solutions in equities, fixed income, alternatives, and money market funds to institutional clients and retail investors; and retirement products and services, brokerage, custody, estate planning, lending, deposits, and investment management products. The company also provides ATM, online and mobile, and telephone banking services. JPMorgan Chase & Co. was founded in 1799 and is headquartered in New York, New York.
Earnings Per Share
As for profitability, JP Morgan Chase has a trailing twelve months EPS of $15.55.
PE Ratio
JP Morgan Chase has a trailing twelve months price to earnings ratio of 9.47. Meaning, the purchaser of the share is investing $9.47 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.93%.
Moving Average
JP Morgan Chase’s worth is below its 50-day moving average of $147.78 and above its 200-day moving average of $141.57.
